Predictive QSAR modeling of phosphodiesterase 4 inhibitors.

A series of diverse organic compounds, phosphodiesterase type 4 (PDE-4) inhibitors, have been modeled using a QSAR-based approach. 48 QSAR models were compared by following the same procedure with different combinations of descriptors and machine learning methods. QSAR methodologies used random forests and associative neural networks. The predictive ability of the models was tested through leave-one-out cross-validation, giving a Q² = 0.66-0.78 for regression models and total accuracies Ac=0.85-0.91 for classification models. Predictions for the external evaluation sets obtained accuracies in the range of 0.82-0.88 (for active/inactive classifications) and Q² = 0.62-0.76 for regressions. The method showed itself to be a potential tool for estimation of IC₅₀ of new drug-like candidates at early stages of drug development.

[1]  Alexander Tropsha,et al.  Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.

[2]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[3]  N. Kang,et al.  Comparative molecular field analysis (CoMFA) for phosphodiesterase (PDE) IV inhibitors , 2007 .

[4]  R. Young,et al.  Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[5]  Robert P. Sheridan,et al.  Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..

[6]  S. Baker,et al.  Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application. , 2010, Bioorganic & medicinal chemistry letters.

[7]  Igor V. Tetko,et al.  Neural Network Studies. 3. Variable Selection in the Cascade-Correlation Learning Architecture , 1998, J. Chem. Inf. Comput. Sci..

[8]  M. Strub,et al.  Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors. , 2004, Bioorganic & medicinal chemistry.

[9]  Tom Tollenaere,et al.  SuperSAB: Fast adaptive back propagation with good scaling properties , 1990, Neural Networks.

[10]  A. Megens,et al.  Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[11]  N. Bodor,et al.  Neural network studies: Part 3. Prediction of partition coefficients , 1994 .

[12]  Igor V. Tetko,et al.  Efficient Partition of Learning Data Sets for Neural Network Training , 1997, Neural Networks.

[13]  M. Toda,et al.  Highly potent PDE4 inhibitors with therapeutic potential. , 2004, Bioorganic & medicinal chemistry letters.

[14]  R. Morphy,et al.  CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[15]  J. Cashman,et al.  Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression. , 2009, Bioorganic & medicinal chemistry.

[16]  J. Wallace,et al.  Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine. , 2000, The Journal of pharmacology and experimental therapeutics.

[17]  Alexander Golbraikh,et al.  QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds , 2008, Pharmaceutical Research.

[18]  Rajarshi Guha,et al.  Utilizing high throughput screening data for predictive toxicology models: protocols and application to MLSCN assays , 2008, J. Comput. Aided Mol. Des..

[19]  Igor V. Tetko,et al.  Neural network studies, 1. Comparison of overfitting and overtraining , 1995, J. Chem. Inf. Comput. Sci..

[20]  T. Keller,et al.  Synthesis and structure-activity relationship of N-arylrolipram derivatives as inhibitors of PDE4 isozymes. , 2001, Chemical & pharmaceutical bulletin.

[21]  B. Charpiot,et al.  Quinazolines: combined type 3 and 4 phosphodiesterase inhibitors. , 1998, Bioorganic & medicinal chemistry letters.

[22]  Yves Chauvin,et al.  A Back-Propagation Algorithm with Optimal Use of Hidden Units , 1988, NIPS.

[23]  Diogo A. R. S. Latino,et al.  Assignment of EC Numbers to Enzymatic Reactions with MOLMAP Reaction Descriptors and Random Forests , 2009, J. Chem. Inf. Model..

[24]  Yann LeCun,et al.  Optimal Brain Damage , 1989, NIPS.

[25]  Yanli Wang,et al.  A novel method for mining highly imbalanced high-throughput screening data in PubChem , 2009, Bioinform..

[26]  Y. Natsumeda,et al.  Preferential inhibition of human phosphodiesterase 4 by ibudilast. , 2006, Life sciences.

[27]  A. Dimoglo,et al.  Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. , 2007, Bioorganic & medicinal chemistry.

[28]  Highly potent PDE4 inhibitors with therapeutic potential. , 2004, Bioorganic & medicinal chemistry.

[29]  Asit K Chakraborti,et al.  3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[30]  S. V. Antonenko,et al.  HIV-1 reverse transcriptase inhibitor design using artificial neural networks. , 1994, Journal of medicinal chemistry.

[31]  E. Ebenso,et al.  ETM-ANN Approach Application for Thiobenzamide and Quinolizidine Derivatives , 2010, Journal of biomedicine & biotechnology.

[32]  Igor V. Tetko,et al.  Neural Network Studies, 2. Variable Selection , 1996, J. Chem. Inf. Comput. Sci..

[33]  Leo Breiman,et al.  Classification and Regression Trees , 1984 .

[34]  Pierre Ducrot,et al.  CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV , 2001, J. Comput. Aided Mol. Des..

[35]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[36]  A. Fassihi,et al.  QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors. , 2009, Journal of molecular graphics & modelling.

[37]  K. R. Maples,et al.  Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis. , 2009, Bioorganic & medicinal chemistry letters.

[38]  Igor V. Tetko,et al.  Neural Network Studies, 4. Introduction to Associative Neural Networks , 2002, J. Chem. Inf. Comput. Sci..

[39]  Ruili Huang,et al.  Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[40]  Weifan Zheng,et al.  Development of Improved Models for Phosphodiesterase-4 Inhibitors with a Multi-Conformational Structure-Based QSAR Method , 2009, Current chemical genomics.

[41]  B. Suh,et al.  Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics. , 2003, Bioorganic & medicinal chemistry letters.

[42]  Asit K Chakraborti,et al.  Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[43]  Weifan Zheng,et al.  A New Structure-Based QSAR Method Affords both Descriptive and Predictive Models for Phosphodiesterase-4 Inhibitors , 2008, Current chemical genomics.

[44]  C. Brullo,et al.  New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms. , 2009, Journal of medicinal chemistry.